Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Clinical Data, Inc.

NEW YORK--(BUSINESS WIRE)--Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Clinical Data, Inc. (NASDAQ: CLDA) (referred to as "Clinical Data" or the “Company”) by Forest Laboratories, Inc. (“Forest”) in a cash transaction valued at approximately $1.2 billion.